APOA1 and type 2 diabetes mellitus: Similar findings have been reported in people with type 2 diabetes, where infusions of reconstituted HDL consisting of apoA-I complexed with phosphatidylcholine increase plasma insulin levels and reduce plasma glucose levels8.